
Mevo Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 5.8/10
Best for: compounded GLP-1 from a small network of named board-certified physicians
Mevo Health scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
Price checked on Mevo Health's site,
What the monthly price covers
Medication
Included
Provider visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Mevo Health (Mevo Health LLC, Delaware) is a direct-pay telehealth service offering compounded semaglutide and tirzepatide injections, prescribed by four named board-certified physicians. Plans are monthly, quarterly or six-month, with semaglutide advertised as low as $199/month and tirzepatide as low as $259; the price for each plan length isn't shown before signup. No insurance needed, a LegitScript seal on-site, and all prescription sales are final.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Mevo Health
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Mevo Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo (starting price)
- What's included
- Medication
- FDA status
- No FDA warning letter on record
How we scored Mevo Health
Each dimension is scored algorithmically from Mevo Health'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
5.5/10Mevo Health's headline is $199/mo. Compare it with other programs on the same plan basis.
Effectiveness25%
6.8/10Mevo Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
5.9/10Online intake and platform experience; 7 platform features disclosed.
Trust & Safety15%
6.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
4.8/10Mevo Health's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
4.6/10Mevo Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Mevo Health review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$259/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Mevo Health
We walked Mevo Health's public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Click Get Started or Learn More on a medication card.
- 2The intake site opens and asks for your email or to create an account before any questions.
- Only 'as low as' starting prices are shown before signup: $199 for semaglutide, $259 for tirzepatide.
- The price for each plan length (monthly, quarterly, six-month) isn't shown before you create an account.
- Both medication cards lead to the same account screen; there is no public plan picker.
- Refund policy says all prescription sales are final and intake fees are non-refundable even if you're not prescribed.
- You can cancel before your next billing cycle by emailing the care team.
Mevo Health customer support
- Phone
- 845-570-3714
- care@mevohealth.com
GLP-1 medications Mevo Health offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Advertised 'as low as $199'. Monthly, quarterly and six-month plans exist; per-plan and per-dose prices appear only after you create an account.
Advertised 'as low as $259'. Monthly, quarterly and six-month plans exist; per-plan and per-dose prices appear only after you create an account.
Ready to get started?
Plans and promotions change often, so check Mevo Health's current pricing and active discounts before you decide.
What we like
- Four named board-certified physicians, with bios, including the head of its provider network
- Publishes the FDA compounded-medication disclaimer
- Starting prices shown on the homepage before you sign up
- Choice of monthly, quarterly or six-month plans
- You can cancel before your next billing cycle
- Operating entity disclosed (Mevo Health LLC, Delaware)
- LegitScript Certified seal on the site
- Ongoing access to your provider team plus a patient community group
Watch-outs
- Only 'as low as' prices are public; your plan and dose price appear after you create an account
- All prescription sales are final, and processed charges are non-refundable
- Intake and consultation fees are non-refundable even if you're not prescribed
- States served not listed on any public page
- Compounding pharmacies are not named, only described as licensed 503A pharmacies
- No titled medical director
- Oral tablet options previously listed are no longer shown on the site
- Footer typo: 'HIPPA Policy' link
Mevo Health: a four-doctor network selling compounded GLP-1 shots
Mevo Health is a small direct-pay telehealth service that sells two drugs: compounded semaglutide and compounded tirzepatide, both as injections. Mevo used to list oral tablets too, but they're no longer on the site. What sets Mevo apart is that you can see exactly who your doctors are before you sign up. The trade-off is that you can't see much of the pricing, or the refund terms, until you look closely.
How the pricing works
Mevo advertises semaglutide "as low as" $199 a month and tirzepatide as low as $259, and you pay Mevo directly with no insurance involved. Plans come in monthly, quarterly and six-month lengths, but Mevo doesn't show what each length costs before you create an account. So the headline figure may be the rate for the longest plan, not the month-to-month price.
There's no per-dose price list either, and no statement that every dose costs the same. For context, even that entry rate sits a little above the category median of $179 a month. Treat the advertised number as a floor and ask for your exact plan and dose price before you pay.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.
- Semaglutide: compounded weekly injection, advertised from $199/month before you pick a plan length
- Tirzepatide: compounded weekly injection, advertised from $259/month before you pick a plan length
- Plans: monthly, quarterly or six-month; the price for each length appears only after you create an account
- No insurance: direct-pay only, with an online consult required before any prescription is written
Refunds and canceling
Mevo's refund policy is strict. It says plainly that "all sales of prescription products through Mevo Health are final." Intake and consultation fees are non-refundable "even if a prescription is not approved." Charges that have already gone through stay put.
Canceling is simpler: you can cancel before your next billing cycle by emailing care@mevohealth.com, and billing stops at the next cycle. Just don't expect money back for the cycle you've already paid for.
What you're getting
Both drugs are compounded, not brand-name. The FDA doesn't review compounded medications for safety, effectiveness or quality before they're dispensed, and Mevo prints that disclaimer on its own site. The drugs come from what Mevo calls licensed 503A U.S. compounding pharmacies, which may vary by your location. Mevo doesn't name them, so you can't look up who is mixing your medication. That's a gap for a drug you'll inject every week for months.
The differentiator: named physicians and a LegitScript seal
Mevo's clinicians are named outright on the homepage, each with a short bio. Dr. David Wasef heads the provider network, and he's joined by Dr. Frank Suppa, Dr. Andrew Sakla and Dr. Constantin Chikando across internal, family and emergency medicine. That's more openness than a lot of cash-pay competitors offer at this price. Mevo also shows a LegitScript seal that links to LegitScript's own checker for its domain.
One thing to know is that Dr. Wasef and Dr. Suppa also appear on a couple of sibling telehealth brands. That's a common pattern in this market, not evidence of anything shady. Mevo Health LLC is its own Delaware company, but the doctors aren't exclusive to it. If you live in Arizona or California and want an office you can visit, MD Trim Clinic pairs telehealth with in-person care from a named DO and NP, though it doesn't publish prices.
The disclosure gaps you should weigh
No state list appears anywhere on the site, so you can't tell whether Mevo operates where you live until you start. There's also no titled medical director, despite the four named physicians. A small footer typo, a "HIPPA Policy" link, doesn't inspire much confidence in how carefully the back office is run. Add the account wall in front of the real prices, and Mevo asks for more trust than it earns up front.
Who should choose Mevo
- Cash-pay shoppers who value named, board-certified doctors over an anonymous prescriber they can't look up
- People who want both semaglutide and tirzepatide from one provider so they can switch drugs without switching platforms
- Anyone comfortable choosing a monthly, quarterly or six-month plan and canceling by email when they're done
Who should skip it
- Anyone who wants an oral tablet instead of a shot, since Mevo now sells injections only
- Shoppers who want to see their exact plan price before handing over an email
- Anyone who wants a refund if not prescribed, since Mevo keeps intake and consultation fees. If that refund matters more to you, Joey Med offers one and shows its plan prices on each product page, though it doesn't name its pharmacy or medical director
- Patients hoping to use insurance or get brand-name Wegovy or Zepbound, which Mevo doesn't offer
The bottom line
Mevo Health earns its place for its named physicians, its printed FDA disclaimer and a starting price from $199. It's a legitimate direct-pay option for compounded semaglutide and tirzepatide injections. Go in knowing the soft spots: unnamed pharmacies, no state list, prices hidden behind an account, and final-sale terms. Confirm your plan cost and whether Mevo serves your state before you pay anything. Our scoring methodology explains how we weigh pricing, oversight and refund terms.
The Bottom Line
Mevo Health scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Mevo Health?
From $199/mo. See current pricing and start your online intake.
Mevo Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Mevo Health vs…
Mevo Health scores5.8/10
Side-by-side pricing, medications and scores. Pick a matchup.
Mevo Health vs Amazon One Medical
Amazon One Medical scores 8.5/10

Mevo Health vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Mevo Health review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Mevo Health's current pricing
Plans from $199/mo. Start the online intake to check eligibility and today's price.